Delay in Seeking Treatment Is Still the Main Barrier in Receiving Acute Stroke Therapy
Author(s) -
Lung Chan
Publication year - 2010
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.586925
Subject(s) - medicine , thrombolysis , stroke (engine) , acute stroke , tissue plasminogen activator , neurology , ischemic stroke , intensive care medicine , emergency medicine , myocardial infarction , ischemia , mechanical engineering , psychiatry , engineering
To the Editor:Although there have been major advances in stroke diagnosis, prevention, and treatment during the past decade, stroke is the still third most common cause of death in Taiwan.1 The intravenous tissue plasminogen activator (tPA) is currently the only approval medical therapy for acute ischemic stroke within a 3-hour window2,3 and …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom